[Report on the Joint 3rd World Stroke Congress and the 5th European Stroke Conference and the International Stroke Trial Conference,Munich, Germany, 8/31-9/5 1996].
Mendel
T
T
II Klinika Neurologiczna, Al. Sobieskiego, Warsaw, Poland.
D001241:Aspirin / Q000627:therapeutic use; D002491:Central Nervous System Agents / Q000627:therapeutic use; D002561:Cerebrovascular Disorders / Q000175:diagnosis / Q000517:prevention & control*; D005858:Germany; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use
D002491:Central Nervous System Agents; D018696:Neuroprotective Agents; D001241:Aspirin